Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
- Sprache
-
Englisch
- Identifier
-
1171905513
Beteiligte Personen und Organisationen
Banas, Bernhard
Steubl, Dominik
Renders, Lutz
Chittka, Dominik
Banas, Miriam C.
Wekerle, Thomas
Koch, Martina
Witzke, Oliver
Mühlfeld, Anja
Sommerer, Claudia
Habicht, Antje
Hugo, Christian
Hünig, Thomas
Lindemann, Monika
Schmidt, Traudel
Rascle, Anne
Barabas, Sascha
Deml, Ludwig
Wagner, Ralf
Krämer, Bernhard K.
Krüger, Bernd
Steubl, Dominik
Renders, Lutz
Chittka, Dominik
Banas, Miriam C.
Wekerle, Thomas
Koch, Martina
Witzke, Oliver
Mühlfeld, Anja
Sommerer, Claudia
Habicht, Antje
Hugo, Christian
Hünig, Thomas
Lindemann, Monika
Schmidt, Traudel
Rascle, Anne
Barabas, Sascha
Deml, Ludwig
Wagner, Ralf
Krämer, Bernhard K.
Krüger, Bernd
- DOI
-
10.18154/RWTH-CONV-222032
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:53 MEZ
Beteiligte
- Banas, Bernhard
- Steubl, Dominik
- Renders, Lutz
- Chittka, Dominik
- Banas, Miriam C.
- Wekerle, Thomas
- Koch, Martina
- Witzke, Oliver
- Mühlfeld, Anja
- Sommerer, Claudia
- Habicht, Antje
- Hugo, Christian
- Hünig, Thomas
- Lindemann, Monika
- Schmidt, Traudel
- Rascle, Anne
- Barabas, Sascha
- Deml, Ludwig
- Wagner, Ralf
- Krämer, Bernhard K.
- Krüger, Bernd
Ähnliche Objekte (12)
Comparison of cytomegalovirus-specific immune cell response to proteins versus peptides using an IFN-γ ELISpot assay after hematopoietic stem cell transplantation
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Hematopoietic Stem and Progenitor Cells Acquire Distinct DNA-Hypermethylation During in vitro Culture
Urinary Exosomes: A Novel Means to Non-Invasively Assess Changes in Renal Gene and Protein Expression
Comparison of cytomegalovirus-specific immune cell response to proteins versus peptides using an IFN-γ ELISpot assay after hematopoietic stem cell transplantation
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Hematopoietic Stem and Progenitor Cells Acquire Distinct DNA-Hypermethylation During in vitro Culture
Urinary Exosomes: A Novel Means to Non-Invasively Assess Changes in Renal Gene and Protein Expression
Comparison of cytomegalovirus-specific immune cell response to proteins versus peptides using an IFN-γ ELISpot assay after hematopoietic stem cell transplantation
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Hematopoietic Stem and Progenitor Cells Acquire Distinct DNA-Hypermethylation During in vitro Culture